I. Peene

发表

Specific presence of intracellular citrullinated proteins in rheumatoid arthritis synovium: Relevance to antifilaggrin autoantibodies

Filip De Keyser, Dominique Baeten, M. Sebbag, 2001 .

Conspicuous synovial lymphatic capillaries in juvenile idiopathic arthritis synovitis with rice bodies

D. Isenberg, I. Peene, A. Union, 2004 .

Rheumatoid factor and anticitrullinated protein antibodies in rheumatoid arthritis: diagnostic value, associations with radiological progression rate, and extra-articular manifestations

C. Vincent, G. Serre, I. Peene, 2004, Annals of the rheumatic diseases.

Treatment of severely ill COVID-19 patients with anti-interleukin drugs (COV-AID): A structured summary of a study protocol for a randomised controlled trial

B. Lambrecht, I. Peene, C. Bosteels, 2020, Trials.

Detection of specific antinuclear reactivities in patients with negative anti-nuclear antibody immunofluorescence screening tests.

I. Peene, E. Veys, F. de Keyser, 2002, Clinical chemistry.

Presence of rheumatoid factor and antibodies to citrullinated peptides in systemic lupus erythematosus

D. Isenberg, I. Peene, A. Union, 2005, Annals of the rheumatic diseases.

Specific antinuclear antibodies are associated with clinical features in systemic lupus erythematosus

D. Isenberg, T. Huizinga, I. Peene, 2004, Annals of the rheumatic diseases.

Anti-Ro52 reactivity is an independent and additional serum marker in connective tissue disease

I. Peene, L. Meheus, E. Veys, 2002, Annals of the rheumatic diseases.

Diagnostic associations in a large and consecutively identified population positive for anti-SSA and/or anti-SSB: the range of associated diseases differs according to the detailed serotype

I. Peene, L. Meheus, F. Keyser, 2002, Annals of the rheumatic diseases.

Risks and benefits of corticosteroids in arthritic diseases in the clinic.

I. Petta, K. De Bosscher, D. Elewaut, 2019, Biochemical pharmacology.

Diagnostic performance and predictive value of rheumatoid factor, anti-citrullinated peptide antibodies, and the HLA shared epitope for diagnosis of rheumatoid arthritis.

H. Pottel, I. Peene, A. Union, 2005, Clinical chemistry.

Prediction models for rheumatoid arthritis during diagnostic investigation: evaluation of combinations of rheumatoid factor, anti-citrullinated protein/peptide antibodies and the human leucocyte antigen-shared epitope

I. Peene, A. Union, L. Meheus, 2006, Annals of the rheumatic diseases.

Sensitivity of the HEp-2000 Substrate for the Detection of Anti-SSA/Ro60 Antibodies

I. Peene, F. de Keyser, E. Veys, 2000, Clinical Rheumatology.

Specific presence of intracellular citrullinated proteins in rheumatoid arthritis synovium: relevance to antifilaggrin autoantibodies.

M. Sebbag, G. Serre, I. Peene, 2001, Arthritis and rheumatism.

Effect of anti-interleukin drugs in patients with COVID-19 and signs of cytokine release syndrome (COV-AID): a factorial, randomised, controlled trial

B. Lambrecht, M. Buyse, C. Legrand, 2021, The Lancet Respiratory Medicine.

Sargramostim to treat patients with acute hypoxic respiratory failure due to COVID-19 (SARPAC): A structured summary of a study protocol for a randomised controlled trial

B. Lambrecht, I. Peene, C. Bosteels, 2020, Trials.

Correction to: Sargramostim to treat patients with acute hypoxic respiratory failure due to COVID-19 (SARPAC): A structured summary of a study protocol for a randomised controlled trial

B. Lambrecht, I. Peene, C. Bosteels, 2020, Trials.

Discriminative power of salivary gland ultrasound in relation to symptom-based endotypes in suspected and definite primary Sjögren's Syndrome.

K. De Boeck, D. Elewaut, I. Peene, 2022, Seminars in arthritis and rheumatism.

The value of separate detection of anti-Ro52, anti-Ro60 and anti-SSB/La reactivities in relation to diagnosis and phenotypes in primary Sjögren's syndrome.

D. Elewaut, I. Peene, F. E. Van den Bosch, 2022, Clinical and experimental rheumatology.

Progressive sensory ataxia and breast implant rupture, an uncommon presentation of a debated concept: a case report

I. Peene, G. Varkas, Sofie Van Assche, 2022, BMC Neurology.

Selection of study endpoints and patients for clinical trials in primary Sjögren's syndrome.

A. Vissink, H. Bootsma, D. Elewaut, 2022, Clinical and experimental rheumatology.

History and Diagnostic Value of Antibodies to Citrullinated Proteins in Rheumatoid Arthritis

I. Peene, L. Derycke, F. de Keyser, 2004, International journal of immunopathology and pharmacology.

Case number 34: Relapse of polyarteritis nodosa presenting as isolated and localised lower limb periostitis

I. Peene, E. Veys, F. de Keyser, 2005, Annals of the rheumatic diseases.

Immune-mediated pathology following hepatitis B vaccination. Two cases of polyarteritis nodosa and one case of pityriasis rosea-like drug eruption.

D. Elewaut, I. Peene, F. de Keyser, 2000, Clinical and experimental rheumatology.

Anakinra in resistant gout: a case report

I. Peene, Y. Piette, E. Dhondt, 2017, Acta clinica Belgica.

Anti-citrullinated protein/peptide antibodies (ACPA) in rheumatoid arthritis: specificity and relation with rheumatoid factor.

I. Peene, F. de Keyser, T. Cantaert, 2005, Autoimmunity reviews.

Changing the wolf from outside: how microbiota trigger systemic lupus erythematosus

D. Elewaut, I. Peene, 2019, Annals of the rheumatic diseases.

Nailfold capillaroscopy in Sjögren's syndrome: a systematic literature review and standardised interpretation.

M. Cutolo, D. Elewaut, I. Peene, 2020, Clinical and experimental rheumatology.

Detection and identification of antinuclear antibodies (ANA) in a large and consecutive cohort of serum samples referred for ANA testing

I. Peene, L. Meheus, F. de Keyser, 2001, Annals of the rheumatic diseases.

Occurrence of scleroderma in monozygotic twins.

L. Messiaen, I. Peene, F. de Keyser, 2000, The Journal of rheumatology.

Analysis of the P Wave with Signal Averaging to Assess the Risk of Atrial Fibrillation after Coronary Artery Bypass Surgery

Luc Jordaens, L. Jordaens, I. Peene, 1997, Cardiology.

Periostitis as the initial manifestation of systemic vasculitis

D. Isenberg, T. Huizinga, I. Peene, 2004, Annals of the rheumatic diseases.

Association between interleukin 6 gene polymorphisms and Behçet ’ s disease in Korean people

I. Peene, A. Union, L. Meheus, 2004 .

Conspicuous synovial lymphatic capillaries in juvenile idiopathic arthritis synovitis with rice bodies

D. Isenberg, I. Peene, A. Union, 2004 .

Conspicuous synovial lymphatic capillaries in juvenile idiopathic arthritis synovitis with rice bodies

D. Isenberg, I. Peene, A. Union, 2004 .

Conspicuous synovial lymphatic capillaries in juvenile idiopathic arthritis synovitis with rice bodies

D. Isenberg, I. Peene, A. Union, 2004 .

Conspicuous synovial lymphatic capillaries in juvenile idiopathic arthritis synovitis with rice bodies

D. Isenberg, I. Peene, A. Union, 2004 .

Conspicuous synovial lymphatic capillaries in juvenile idiopathic arthritis synovitis with rice bodies

D. Isenberg, I. Peene, A. Union, 2004 .

Conspicuous synovial lymphatic capillaries in juvenile idiopathic arthritis synovitis with rice bodies

D. Isenberg, I. Peene, A. Union, 2004 .

Association between interleukin 6 gene polymorphisms and Behçet ’ s disease in Korean people

I. Peene, A. Union, L. Meheus, 2004 .

Conspicuous synovial lymphatic capillaries in juvenile idiopathic arthritis synovitis with rice bodies

D. Isenberg, I. Peene, A. Union, 2004 .

Treatment of severely ill COVID-19 patients with anti-interleukin drugs (COV-AID): A structured summary of a study protocol for a randomised controlled trial.

B. Lambrecht, I. Peene, C. Bosteels, 2020 .

Erratum: Correction to: Treatment of severely ill COVID-19 patients with anti-interleukin drugs (COV-AID): A structured summary of a study protocol for a randomised controlled trial (Trials (2020) 21 1 (468))

I. Peene, C. Bosteels, M. Vuylsteke, 2020 .

Peripheral manifestations are major determinants of disease phenotype and outcome in new onset spondyloarthritis.

M. D’Agostino, F. Costantino, D. Elewaut, 2021, Rheumatology.